Literature DB >> 20453661

Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas.

Takuya Mimura1, Atsuhiro Masuda, Ippei Matsumoto, Hideyuki Shiomi, Shiei Yoshida, Maki Sugimoto, Tsuyoshi Sanuki, Masaru Yoshida, Tsuyoshi Fujita, Hiromu Kutsumi, Yonsou Ku, Takeshi Azuma.   

Abstract

GOALS: The predictors of malignant intraductal papillary mucinous neoplasm (IPMN) and invasive IPMN were investigated in this study to determine the optimal indicators of surgical resection for IPMN.
BACKGROUND: Recently, international consensus guidelines have described the standard indicators of resection for IPMN. However, the indicators of surgical resection for IPMN, especially for branch duct IPMN, still remain controversial. STUDY: Eighty-two patients with IPMN who underwent surgical resection during April 1998 to January 2009, were retrospectively reviewed and examined with regard to their preoperative factors and pathologic diagnosis.
RESULTS: Multivariate analysis showed that main duct IPMN (P<0.01) and earlier diabetes (P=0.03) were independent predictors of malignant IPMN. In branch duct IPMN, the diameter of the main pancreatic duct (MPD) was found to be significantly associated with malignancy by univariate analysis (P=0.034). An elevated serum CA19-9 level (P<0.01) was an independent predictor of invasive IPMN.
CONCLUSIONS: Our observations suggest that main duct IPMN, branch duct IPMN with MPD dilatation, and IPMN with an elevated serum CA19-9 level should be considered as indications for surgical resection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20453661     DOI: 10.1097/MCG.0b013e3181d8fb91

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  31 in total

1.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

2.  Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia.

Authors:  Michele T Yip-Schneider; Rosalie A Carr; Huangbing Wu; C Max Schmidt
Journal:  J Am Coll Surg       Date:  2017-07-21       Impact factor: 6.113

3.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

4.  Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms.

Authors:  Mariko Tsukagoshi; Kenichiro Araki; Fumiyoshi Saito; Norio Kubo; Akira Watanabe; Takamichi Igarashi; Norihiro Ishii; Takahiro Yamanaka; Ken Shirabe; Hiroyuki Kuwano
Journal:  Dig Dis Sci       Date:  2017-06-30       Impact factor: 3.199

5.  Radiological predictors of malignant transformation of IPMNs: importance of the predictive model validation: Author reply.

Authors:  Albert Strauss
Journal:  Br J Radiol       Date:  2016-07-05       Impact factor: 3.039

Review 6.  Comparative Effectiveness of Resection vs Surveillance for Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasms With Worrisome Features.

Authors:  Yinin Hu; Lily E. Johnston; Vanessa M. Shami; Todd W. Bauer; Reid B. Adams; George J. Stukenborg; Victor M. Zaydfudim
Journal:  JAMA Surg       Date:  2018-03-01       Impact factor: 14.766

7.  Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.

Authors:  Mee Joo Kang; Jin-Young Jang; Selyeong Lee; Taesung Park; Seung Yeoun Lee; Sun-Whe Kim
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

8.  Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.

Authors:  Albert Strauss; Matthew Birdsey; Stefan Fritz; Bogata D Schwarz-Bundy; Frank Bergmann; Thilo Hackert; Hans-Ullrich Kauczor; Lars Grenacher; Miriam Klauss
Journal:  Br J Radiol       Date:  2016-03-09       Impact factor: 3.039

Review 9.  Endoscopic retrograde pancreatography: When should we do it?

Authors:  Renáta Bor; László Madácsy; Anna Fábián; Attila Szepes; Zoltán Szepes
Journal:  World J Gastrointest Endosc       Date:  2015-08-25

10.  Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Mathieu Daudé; Fabrice Muscari; Camille Buscail; Nicolas Carrère; Philippe Otal; Janick Selves; Louis Buscail; Barbara Bournet
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.